Maquiladoras which avoid most tariffs because their finished products are for export only, have boomed since the 1994 North American Free Trade Agreement.
Governments’ emergency actions in the wake of COVID-19 could prompt a wave of arbitration lawsuits for billions of dollars by multinational corporations and investment lawyers.
Peruvian officials have warned that a proposed emergency measure suspending the collection of toll fees on the country’s road network in response to the outbreak of covid-19 could result in multiple ICSID claims.
Governments are facing an imminent threat of investor–state arbitration as they take difficult decisions to support public health systems in a time of severe economic stress.
States around the world have taken a variety of measures seeking to stem the spread of COVID-19. It is likely that some foreign investors may seek relief and/or compensation for any losses resulting from State measures.
Allegedly arbitrary or disproportionate measures, albeit in the public interest, provide regular grist for the mill of investment treaty arbitration.
In order to halt the spread of the coronavirus pandemic (Covid-19) and to boost the public health care system and preparedness, India has taken several regulatory steps.
The agreement does not promise that the suspended provision on test data rule concerning biological medicines will remain suspended.
If the intellectual property provisions of the DCFTA are applied, this will have an impact on both the cost of patented medicines and undermine access to affordable medicines.
Campaigners fear that EU rules banning dangerous chemicals will be relaxed to allow American companies into UK market.
Corporate-led trade deals put us all in danger when it comes to tacking future health crises, writes Caroline Lucas MP.
India has offered to partially open up its poultry and dairy markets in a bid for a limited trade deal during US President Donald Trump’s first official visit.
Donald Trump will put the interests of corporate America first and demand that the NHS pays higher prices for US drugs in a free-trade deal with the UK, the outgoing British ambassador to Washington said.
Even though US negotiators were forced by public opposition to remove language explicitly banning front-of-package graphic labels from New NAFTA, other provisions of concern remain in the trade deal.
Behind the bluster about “getting Brexit done” is an ambitious long term agenda: to realign our economy and our standards with the interests of American business.
Neither Boris Johnson nor Donald Trump deny evidence of secret talks as NHS is under attack by ’market’ ideologues in a privatising policy which began with Thatcher.
Mexico’s government said progress was being made toward revising a new North American trade pact that will sharply reduce protections for biologic drugs.
Generic versions of biologic drugs could come to market faster.
There are two solutions to this impending problem, which most political parties could agree to if they are truly committed to protecting the NHS.
The US is exporting ever-more processed foods, as well as meat, to the region, while making it harder for farmers there to supply healthy foods for the local market.